NanoBio’s Deal With GlaxoSmithKline Tabbed Deal Of Distinction
ANN ARBOR - NanoBio Corporation Wednesday announced that the company's licensing agreement with GlaxoSmithKline has been recognized by the Licensing Executive Society as the 2009 consumer products "Deal of Distinction." LES recognizes noteworthy deals in five industry sectors that promote innovation solutions to business issues and deal structures. On December 16, 2009, NanoBio announced an